stages alzheimer earlier study presenilin-1 findings highlight potential therapies target protein degradation pathways help cells deal buildup harmful pathologic molecules need new approaches comes stark relief alzheimer association begins week toronto alzheimer disease treatments fundamentally alter course disease trial trial drug candidates ended failure research parkinson huntington uncovered additional examples disease proteins mutated stymie protein clearance pathways neurons cuervo group found mutant protein associated heritable version parkinson leads protein alpha synuclein build form toxic clumps brain areas control motor function year cuervo collaborated sheng zhang professor university texas health science center houston experiments showing huntingtin huntington disease protein helps cell